Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Idenix Pharma Buyout Likely: Survey
The Street
Saturday, January 21, 2012 - 12:53pm
tags:
Idenix
Infinity Reports New Data from Phase 1b Trial of Saridegib in Patients with Pancreatic Cancer at ASCO-GI
Yahoo/BusinessWire
Saturday, January 21, 2012 - 12:51pm
tags:
Infinity Pharmaceuticals, saridegib, pancreatic cancer
Exelixis Reports Positive Preliminary Phase 2 Cabozantinib Data in Patients with Hepatocellular Carcinoma
Yahoo/BusinessWire
Saturday, January 21, 2012 - 12:41pm
tags:
Exelixis, cabozantinib, hepatocellular carcinoma
Alnylam Pharma says it will cut 33 percent of jobs
Yahoo/AP
Saturday, January 21, 2012 - 12:31pm
tags:
Alnylam
FDA lifts hold on Insmed's lung disease drug
Reuters
Saturday, January 21, 2012 - 12:26pm
tags:
Insmed, Arikace, cystic fibrosis, non-tuberculous mycobacteria
Could These Huge Health-Care Buyouts Continue?
Motley Fool
Saturday, January 21, 2012 - 12:20pm
tags:
M&A
Is ViroPharma's Growth for Real?
Motley Fool
Saturday, January 21, 2012 - 12:18pm
tags:
ViroPharma
Achillion shares fall on concerns over hep C drug's future
Reuters
Saturday, January 21, 2012 - 12:04pm
tags:
Achillion
Cubicin Drives Cubist Pharma
Yahoo/Zacks
Saturday, January 21, 2012 - 12:02pm
tags:
Cubicin, Cubist Pharmaceuticals, antibiotics
Is Biogen's Stock Reasonable by the Numbers?
Motley Fool
Saturday, January 21, 2012 - 12:00pm
tags:
Biogen
Sequenom expects to raise $54M from stock sale
Yahoo/AP
Friday, January 20, 2012 - 12:24pm
tags:
stock offering, Sequenom
Novartis falls 4% on MS drug concerns
Marketwatch
Friday, January 20, 2012 - 12:19pm
tags:
MS, Novartis, Gilenya, multiple sclerosis
Drug lobby wants clearer FDA rules for diet pills
Reuters
Friday, January 20, 2012 - 11:32am
tags:
FDA, diet pills, PhRMA, PDUFA, Sanofi
Biotechnology Funding Hits 4-Year High
Bloomberg
Friday, January 20, 2012 - 11:29am
tags:
funding, biotech
Forbes Earnings Preview: Abbott Laboratories
Forbes
Friday, January 20, 2012 - 11:23am
tags:
earnings, Abbott Laboratories
Novartis’s Gilenya Reviewed After 11 Deaths
Bloomberg
Friday, January 20, 2012 - 10:06am
tags:
Novartis, Gilenya, MS, multiple sclerosis, EMA
No Vacancy: Workers Need Not Apply to This Sector
Motley Fool
Friday, January 20, 2012 - 10:02am
tags:
layoffs, pharma industry
Cubist Pharma 4Q profit falls 53 percent
Yahoo/AP
Friday, January 20, 2012 - 9:59am
tags:
earnings, Cubist Pharmaceuticals
Dividends, Drug Stocks And Owner Earnings
Seeking Alpha
Friday, January 20, 2012 - 9:59am
tags:
dividends, drug stocks, Merck, Eli Lilly, Pfizer, Bristol-Myers Squibb
Genzyme, Veracyte announce global co-promotion agreement
The Fly on the Wall
Friday, January 20, 2012 - 9:57am
tags:
Genzyme, Veracyte, Afirma Thyroid FNA Analysis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.